Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002615 |
---|---|
Receipt number | R000003192 |
Scientific Title | Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin for extensive disease small cell lung cancer |
Date of disclosure of the study information | 2009/11/01 |
Last modified on | 2020/02/03 10:21:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/12 11:18:28 | ||
2 | Update | 2010/03/25 15:47:42 | Recruitment status |
|
3 | Update | 2010/04/12 11:54:47 | Recruitment status |
|
4 | Update | 2010/04/12 11:57:12 | Recruitment status |
|
5 | Update | 2010/10/14 10:33:58 | Name of person sending information Organization Division name Address |
|
6 | Update | 2011/10/12 16:26:56 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2013/04/04 14:27:12 | Recruitment status |
|
8 | Update | 2017/04/18 13:09:24 | Recruitment status |
|
9 | Update | 2020/02/03 10:21:42 | Recruitment status Date of IRB |